80 results on '"Miravitlles, Marc"'
Search Results
2. Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy.
3. Pulmonologists' Opinion on the Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease Patients in Spain: A Cross-Sectional Survey.
4. Diaphragmatic Movement at Rest and After Exertion: A Non-Invasive and Easy to Obtain Prognostic Marker in COPD.
5. The Impact of Chronic Bronchial Infection in COPD: A Proposal for Management.
6. A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid.
7. Long-Term Risk of Mortality Associated with Isolation of Pseudomonas aeruginosa in COPD: A Systematic Review and Meta-Analysis.
8. Inhaled Corticosteroid Use Among COPD Patients in Primary Care in Spain.
9. Opinions and Attitudes of Pulmonologists About Augmentation Therapy in Patients with Alpha-1 Antitrypsin Deficiency. A Survey of the EARCO Group.
10. Economic Impact of Low Adherence to COPD Management Guidelines in Spain.
11. Estimated Prevalence and Number of PiMZ Genotypes of Alpha-1 Antitrypsin in Seventy-Four Countries Worldwide.
12. CONQUEST Quality Standards: For the Collaboration on Quality Improvement Initiative for Achieving Excellence in Standards of COPD Care.
13. Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammation
14. Burden of Disease Among Exacerbating Patients with COPD Treated with Triple Therapy in Spain.
15. Update on Asthma–COPD Overlap (ACO): A Narrative Review.
16. Trends in Diagnosis of Alpha-1 Antitrypsin Deficiency Between 2015 and 2019 in a Reference Laboratory.
17. The Experience of COPD Patients in Lockdown Due to the COVID-19 Pandemic.
18. Relationship Between Clinical Control, Respiratory Symptoms and Quality of Life for Patients with COPD.
19. A Proposed Approach to Chronic Airway Disease (CAD) Using Therapeutic Goals and Treatable Traits: A Look to the Future.
20. Estimation of the Clinical and Economic Impact of an Improvement in Adherence Based on the Use of Once-Daily Single-Inhaler Triple Therapy in Patients with COPD.
21. Easy to Perform Physical Performance Tests to Identify COPD Patients with Low Physical Activity in Clinical Practice.
22. Association Between Routine Blood Biomarkers and Clinical Phenotypes and Exacerbations in Chronic Obstructive Pulmonary Disease.
23. Time To Revise COPD Treatment Algorithm.
24. Comparison of clinical baseline characteristics between Asian and Western COPD patients in a prospective, international, multicenter study.
25. Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms.
26. Validation of clinical control in COPD as a new tool for optimizing treatment.
27. Evaluating the impact of morning symptoms in COPD using the Capacity of Daily Living during the Morning (CDLM) questionnaire.
28. How whole-body vibration can help our COPD patients. Physiological changes at different vibration frequencies.
29. Prevalence of smoking in a psychiatric hospital and its relationship with respiratory symptoms and the prevalence of COPD.
30. Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study.
31. Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study.
32. Long-term evolution of lung function in individuals with alpha-1 antitrypsin deficiency from the Spanish registry (REDAAT).
33. Depressive status explains a significant amount of the variance in COPD assessment test (CAT) scores.
34. Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.
35. Russian guidelines for the management of COPD: algorithm of pharmacologic treatment.
36. Gene and miRNA expression profiles in PBMCs from patients with severe and mild emphysema and PiZZ alpha1-antitrypsin deficiency.
37. Characteristics of COPD patients according to GOLD classification and clinical phenotypes in the Russian Federation: the SUPPORT trial.
38. Joint statement for the diagnosis, management, and prevention of chronic obstructive pulmonary disease for Gulf Cooperation Council countries and Middle East-North Africa region, 2017.
39. Impact and prevention of severe exacerbations of COPD: a review of the evidence.
40. When is dual bronchodilation indicated in COPD?
41. Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study.
42. Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.
43. Alpha-1 antitrypsin Pi*SZ genotype: estimated prevalence and number of SZ subjects worldwide.
44. Palliative care and prognosis in COPD: a systematic review with a validation cohort.
45. Bronchiectasis in COPD patients: more than a comorbidity?
46. Self-reported daily walking time in COPD: relationship with relevant clinical and functional characteristics.
47. Characteristics of COPD patients initiating treatment with aclidinium or tiotropium in primary care in Catalonia: a population-based study.
48. Alpha-1 antitrypsin Pi*Z gene frequency and Pi*ZZ genotype numbers worldwide: an update.
49. Application of a diagnostic algorithm for the rare deficient variant Mmalton of alpha-1-antitrypsin deficiency: a new approach.
50. Diagnosis of alpha-I antitrypsin deficiency: a population-based study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.